Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination

Vaccination has made a substantial contribution to global health improvement throughout history. The coronavirus disease 2019 (COVID-19) vaccinations have provided us with a ray of hope for combatting the ongoing pandemic and saving lives. However, following COVID-19 vaccination, a wide spectrum of...

Descripción completa

Detalles Bibliográficos
Autor principal: Shanshal, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329707/
https://www.ncbi.nlm.nih.gov/pubmed/35911257
http://dx.doi.org/10.7759/cureus.26383
_version_ 1784757979626602496
author Shanshal, Mohammed
author_facet Shanshal, Mohammed
author_sort Shanshal, Mohammed
collection PubMed
description Vaccination has made a substantial contribution to global health improvement throughout history. The coronavirus disease 2019 (COVID-19) vaccinations have provided us with a ray of hope for combatting the ongoing pandemic and saving lives. However, following COVID-19 vaccination, a wide spectrum of cutaneous adverse effects have been observed. We report a case of dyshidrosiform bullous pemphigoid, a rare clinical variant of bullous pemphigoid, following COVID-19 vaccination in an elderly female patient. The biopsy revealed subepidermal splitting with positive direct and indirect immunofluorescence studies.
format Online
Article
Text
id pubmed-9329707
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-93297072022-07-28 Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination Shanshal, Mohammed Cureus Dermatology Vaccination has made a substantial contribution to global health improvement throughout history. The coronavirus disease 2019 (COVID-19) vaccinations have provided us with a ray of hope for combatting the ongoing pandemic and saving lives. However, following COVID-19 vaccination, a wide spectrum of cutaneous adverse effects have been observed. We report a case of dyshidrosiform bullous pemphigoid, a rare clinical variant of bullous pemphigoid, following COVID-19 vaccination in an elderly female patient. The biopsy revealed subepidermal splitting with positive direct and indirect immunofluorescence studies. Cureus 2022-06-28 /pmc/articles/PMC9329707/ /pubmed/35911257 http://dx.doi.org/10.7759/cureus.26383 Text en Copyright © 2022, Shanshal et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Shanshal, Mohammed
Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination
title Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination
title_full Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination
title_fullStr Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination
title_full_unstemmed Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination
title_short Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination
title_sort dyshidrosiform bullous pemphigoid triggered by covid-19 vaccination
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329707/
https://www.ncbi.nlm.nih.gov/pubmed/35911257
http://dx.doi.org/10.7759/cureus.26383
work_keys_str_mv AT shanshalmohammed dyshidrosiformbullouspemphigoidtriggeredbycovid19vaccination

Ejemplares similares